BIOREGENX, INC. 10-Q filing
Filed 2025-11-14 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001683168-25-008429
- Form type
- 10-Q
- CIK
- 0001593184
- Primary document
- https://www.sec.gov/Archives/edgar/data/1593184/000168316825008429/bioregenx_i10q-093025.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOREGENX, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $1.5M | - | - |
| Cost Of Revenue | $283,989 | - | - |
| Gross Profit | $1.2M | - | - |
| Operating Income | $-308,333 | - | - |
| Net Income | $-525,764 | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Total Assets | $1.2M | - | - |
| Total Liabilities | $4.8M | - | - |
| Shareholders Equity | $-3.6M | - | - |
| Operating Cash Flow | $-30,664 | - | - |
| Capital Expenditures | $6,000 | - | - |